Vicarious Surgical Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $249.1K
- Price
- $0.035
- % Change (Daily % change from the live per-ticker quote feed.)
- -6.90%
- Volume
- 130.3K
About
Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.
Quick stats
Shares outstanding7.1M
Computed float3.9M
Float / shares54.3%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001812173
AI Summary
AI-generated1/2
minorneutralearnings
Vicarious Surgical Reports First Quarter 2026 Financial Results
Vicarious Surgical reported Q1 2026 operating expenses of $7.5 million, a 52% decrease from the prior year, which helped narrow the net loss to $7.3 million or $1.03 per share.
The company maintained its full-year 2026 cash burn guidance of approximately $19 million, ending the quarter with $1.4 million in cash and cash equivalents and $2.3 million in short-term investments.
The development-stage firm continues to advance its Vicarious Surgical System, a single-port robotic surgery technology, while focusing on cost discipline to extend its financial runway.
Red flags
- Cash and cash equivalents of $1.4 million are insufficient to cover the guided $19 million full-year cash burn without significant external financing.